Comparison of Metabolic and Morphological Response Criteria for Early Prediction of Response and Survival in NSCLC Patients Treated With Anti-PD-1/PD-L1.

Castello, Angelo; Rossi, Sabrina; Toschi, Luca; Lopci, Egesta

Castello, Angelo; Rossi, Sabrina; Toschi, Luca; Lopci, Egesta.

Afiliação

Castello A; Department of Nuclear Medicine, Humanitas Clinical and Research Hospital-IRCCS, Milan, Italy.
Rossi S; Medical Oncology, Humanitas Clinical and Research Hospital-IRCCS, Milan, Italy.
Toschi L; Medical Oncology, Humanitas Clinical and Research Hospital-IRCCS, Milan, Italy.
Lopci E; Department of Nuclear Medicine, Humanitas Clinical and Research Hospital-IRCCS, Milan, Italy.

Front Oncol ; 10: 1090, 2020.

Article em En | MEDLINE | ID: mdl-32850315

Palavras-chave

18F-FDG PET/CT; EORTC; PERCIMT; PERCIST; RECIST; checkpoint inhibitors; imPERCIST; non-small cell lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google